Soleno Therapeutics, Inc. (SLNO): Price and Financial Metrics


Soleno Therapeutics, Inc. (SLNO): $2.81

0.22 (+8.49%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add SLNO to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

SLNO Stock Price Chart Interactive Chart >

Price chart for SLNO

SLNO Price/Volume Stats

Current price $2.81 52-week high $6.30
Prev. close $2.59 52-week low $0.85
Day low $2.57 Volume 110,053
Day high $2.84 Avg. volume 275,911
50-day MA $1.63 Dividend yield N/A
200-day MA $2.13 Market Cap 22.93M

Soleno Therapeutics, Inc. (SLNO) Company Bio


Soleno Therapeutics, Inc. focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. The company’s lead candidate, diazoxide choline controlled-release (DCCR), a once-daily oral tablet for the treatment of Prader-Willi Syndrome (PWS), is entering into Phase II/III clinical development. It also markets medical devices, including the CoSense End-Tidal Carbon Monoxide (ETCO) monitor, which measures ETCO and is used by hospitals to detect hemolysis in newborns; and NeoPip T-piece resuscitator and related consumables, which deliver consistent pre-set inspiratory pressure and positive end-expiratory pressures, as well as temperature probes, scales, surgical tables, and patient surfaces. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. May 2017. Soleno Therapeutics, Inc. was founded in 1999 and is based in Redwood City, California.


SLNO Latest News Stream


Event/Time News Detail
Loading, please wait...

SLNO Latest Social Stream


Loading social stream, please wait...

View Full SLNO Social Stream

Latest SLNO News From Around the Web

Below are the latest news stories about SOLENO THERAPEUTICS INC that investors may wish to consider to help them evaluate SLNO as an investment opportunity.

Soleno Therapeutics, Inc. (SLNO) Upgraded to Strong Buy: What Does It Mean for the Stock?

Soleno Therapeutics, Inc. (SLNO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Yahoo | January 13, 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

The final day of trading this week is here and we're starting it off with a look at the biggest pre-market stock movers for Friday!

William White on InvestorPlace | January 6, 2023

Soleno Therapeutics Inc. (NASDAQ: SLNO) Recovered 42.18% From The 52-Week Low, And Now It’s -76.10% YTD – This Is What You Do Now

Soleno Therapeutics Inc. (NASDAQ:SLNO)’s traded shares stood at 2.29 million during the last session, with the company’s beta value hitting 0.35. At the close of trading, the stock’s price was $1.47. The SLNO share’s 52-week high remains $8.13, putting it -453.06% down since that peak but still an impressive 42.18% since price per share fell … Soleno Therapeutics Inc. (NASDAQ: SLNO) Recovered 42.18% From The 52-Week Low, And Now It’s -76.10% YTD – This Is What You Do Now Read More »

Marketing Sentinel | December 22, 2022

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tueday

We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to know about on Tuesday morning!

William White on InvestorPlace | December 20, 2022

Why Is Soleno Therapeutics (SLNO) Stock Up 130% Today?

With Soleno Therapeutics receiving a financial commitment, SLNO stock skyrocketed.

Josh Enomoto on InvestorPlace | December 19, 2022

Read More 'SLNO' Stories Here

SLNO Price Returns

1-mo 43.37%
3-mo 167.62%
6-mo 9.55%
1-year -41.62%
3-year -94.41%
5-year -89.90%
YTD 41.92%
2022 -67.80%
2021 -78.76%
2020 -34.35%
2019 71.93%
2018 -5.00%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7001 seconds.